Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis.
In the treatment of active chronic hepatitis and hepatocellular carcinoma some effective drugs can produce myelosuppression. Hypersplenism may considerably limit the dosage of such drugs. Splenectomy is an effective treatment for hypersplenism, although it is not without complications. Partial splenic embolization is a good and safe procedure; 15 patients were treated in order to achieve higher platelet and leukocyte counts. Embolization has been performed with gelfoam with local and systemic antibiotics (Spigos' protocol) and 50-75% of the splenic parenchyma was infarcted. All patients could be treated for the underlying hepatopathy with adequate dosages of interferon or chemotherapeutic drugs.
Bilbao
J I
JI
Department of Radiology, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona, Spain.
Sangro
B
B
Longo
J M
JM
Zozaya
J M
JM
Fernández-Virgós
A
A
Aquerreta
J D
JD
Beloqui
O
O
Prieto
J
J
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005781:Gelatin Sponge, Absorbable; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D013154:Spleen